GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials
On Thursday, GSK (NYSE: GSK), the British drugmaker, announced positive results from a mid-stage trial of its seasonal influenza vaccine […]
GSK (NYSE: GSK) Advances mRNA Flu Vaccine to Late-Stage Trials Read More »